PARAGON BIOSCIENCES EMALEX CAPITAL, INC.

Profile

Company Names

PARAGON BIOSCIENCES EMALEX CAPITAL, INC.

Addresses

303 N WABASH AVE, SUITE # 3500, CHICACO, IL 60611

330 N. WABASH, SUITE 3500, CHICAGO, IL 60611

1033 SKOKIE BOULEVARD, SUITE #600, NORTHBROOK, IL 60062

Phone Numbers

(847) 715-0606

 

Entity Type:

CORPORATION

Industry:

PHARMACEUTICALS

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$536,798,366.00

Number of Funding Rounds:

5
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
5
2022-10-21 
$185,000,000.00 
$250,000,000.00 
$65,000,000.00 
Equity 
4
2022-05-18 
$270,000,000.00 
$270,000,000.00 
$0.00 
Equity 
3
2021-02-25 
$35,000,010.00 
$35,000,010.00 
$0.00 
Equity 
2
2019-09-18 
$37,423,356.00 
$37,423,356.00 
$0.00 
Equity 
1
2018-07-31 
$9,375,000.00 
$9,375,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
JEFFREY 
 
DAYNO 
DIRECTOR
ERIC 
 
MESSNER 
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-18 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-05-18 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-21 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2022-10-21 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Debt 
2022-05-18 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-25 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2021-02-25 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-18 
D/A
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-31 
D
PHARMACEUTICALS 
 
DECLINE TO DISCLOSE 
Equity 
2018-07-31 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
NONE
NONE
PARAGON HEALTH CAPITAL, LLC
NONE
NONE
PARAGON HEALTH CAPITAL, LLC